tirzepatide lawsuit fda Compounders lose battle over Eli Lilly weight loss drug and shortage list FDA says shortage of GLP-1

373 doi: (Published 11 May 2021) Cite this as: BMJ 2021;373:n1091 Visual summary of recommendation BMJ Publishing Group Limited

Skip it if youd rather have a nasal spray or a cream than a needle, or if you need to feel something this week

The precautionary approach exists because pregnancy involves critical windows of organ development where any medication exposure carries theoretical risk

The FDA issued a Drug Safety Communication in 2024 stating that their review did not find clear evidence of an increased risk of suicidal thoughts or actions with GLP-1 receptor agonists, though they continue to evaluate this safety concern